Publications and Publicity a. Contractor shall not issue or publish any book, article, report or other publication related to the Services provided pursuant to this Agreement without first obtaining written prior approval from the College. Any such printed matter or other publication shall contain the following statement in clear and legible print:
b. The College shall have the right of prior approval of press releases and any other information provided to the media, in any form, concerning the Services provided pursuant to this Agreement.
Publications and Publicity. 15.1 The Research Activity will be given the name set out in Schedule 1.
15.2 Cancer Council Xxxxxxxx must be given the opportunity to participate in all media releases relating to the Research Activity, which must be in a form satisfactory to Cancer Council Victoria.
15.3 Any publications whether during or after the Term, resulting from the Research Activity must, in the form satisfactory to Cancer Council Victoria, acknowledge and state prominently that the study was supported by the Postdoctoral Research Fellowship Scheme administered by Cancer Council Victoria. Cancer Council Victoria requires that all such publications made during the Term be listed in the final report given under this Agreement and that it be furnished with one electronic copy of each such publication.
15.4 Any conference presentations during and after the Term, including both oral and poster presentations, or presentations at any internal or external event including but not limited to a workshop, symposium or training event, must acknowledge and state prominently in the form satisfactory to Cancer Council Victoria that the study was supported by the Postdoctoral Research Fellowship Scheme administered by Cancer Council Victoria. Cancer Council Victoria requires that all such presentations be listed in the annual reports given under this Agreement.
15.5 Cancer Council Victoria requires that any publications resulting from the Research Activity and presentations provided after the Term, be notified to Cancer Council Victoria within 14 days of such publication or presentation. Any publications notified to Cancer Council Xxxxxxxx must be accompanied with one electronic copy of the publication or presentation.
15.6 When releasing results derived from the Research Activity to the media, Cancer Council Xxxxxxxx's support must be acknowledged in the form satisfactory to Cancer Council Victoria. Cancer Council Xxxxxxxx must be given the opportunity to participate in all media releases relating to the Research Activity.
15.7 The authors of the reports are solely responsible for the veracity of the published data.
Publications and Publicity. 7.1 Each Party may include the other Party’s name and logo on its website and marketing materials so long as any such usage is limited to reporting factual events or occurrences only (for example, referencing the fact that the partnership is occurring) and does not constitute a commercial endorsement of the products and services of the other Party. Either Party may issue a press release announcing the relationship governed by this Agreement provided that the form and substance of each such release must be approved in advance by both Parties, which approval shall not be unreasonably withheld or delayed.
7.2 Advaxis shall have sole right to present and/or publish the results of the Projects hereunder as they relate to the Clinical Trial or the Product. In any such publication or presentation, Advaxis will acknowledge Stendhal’s contribution (including authorship if appropriate under the circumstances and customary practice). Publication regarding any other clinical trials or data must be agreed upon in advance as between the Parties.
Publications and Publicity a. Service Provider shall not make any publication, lecture, manuscript, poster presentation or other disclosure or dissemination (oral or written) containing information or referring to the services or deliverables or identifying the Receiver as recipient of these services, either during the term of the Service Agreement or after its early termination or expiration, without the prior written approval of the Receiver.
b. Service Provider shall not disclose the details of the Service Agreement to any third party by any means whatsoever, without the prior written permission of the Receiver.
c. Service Provider shall not use or authorize others to use the name, symbols, or marks of the Receiver in any advertising or publicity material or make any form of representation or statement with regard to Services which would constitute an express or implied endorsement by Service Provider of any commercial product or service without the Receiver’s prior written approval.
Publications and Publicity a. The Consultant shall not issue or publish any book, article, report or other publication related to the services provided pursuant to this Agreement without first obtaining written prior approval from the County. Any such printed matter or other publication shall contain the following statement in clear and legible print: “This publication is fully or partially funded by the County of Suffolk.”
b. The Consultant shall not issue any press releases or provide any other information to the media, in any form, without first obtaining written approval from the Department.
Publications and Publicity. Authorship of publications emanating from the use of the Materials hereunder must be in keeping with the International Committee of Medical Journal Editors Authorship Guidelines (xxxx://xxx.xxxxx.xxx/icmje-recommendations.pdf) as amended from time to time. Where the Recipient wishes to publish any information concerning the Project (in either oral or written form), the Provider must be notified and provided with a copy of the publication at least ten (10) days prior to submission of the proposed publication. The Provider must inform the Recipient whether any information related to the publication must be removed or included and provide reasons to substantiate the removal or addition of such information. The Provider must be supplied with a final copy of the publication before publication by the Recipient. The Recipient must acknowledge the Provider’s contribution of the Material unless otherwise requested by the Provider. Neither Party shall use the name of the other Party or its employees in any advertisement, press release or other publicity without prior written approval of the other Party. Notwithstanding the above, and where relevant, publications must be subjected to the applicable protocol and relevant third party agreements.
Publications and Publicity. 8.1. All publications resulting from research carried out under the Funding (Publications) must acknowledge the Funding provided by the CCQ and state prominently that the Project was supported by an Accelerating Collaborative Cancer Research grant awarded by CCQ. The Administering Institution must provide CCQ with two electronic copies of each Publication.
8.2. The Administering Institution grants to the CCQ a perpetual, royalty-free, world- wide irrevocable, non-exclusive, non-transferable licence to use, reproduce, distribute, publish and adapt the Publications for its own non-commercial use including for the purposes of promoting the research funded by the CCQ.
8.3. The authors of the publications are solely responsible for the veracity of the published data.
8.4. The Administering Institution will (and will ensure that Investigator A will) actively promote the awarding of the Project and the significance of the Project by a joint press release which is intended for key local and state media.
8.5. When the Administering Institution or Investigator A releases details of the Project to the media or through publications and reports of the Administering Institution, the Administering Institution must ensure that CCQ’s support is acknowledged. CCQ must be given the opportunity to participate in media releases, and no media release shall be made without the prior written approval of CCQ; such approval is not to be unreasonably withheld.
8.6. The Administering Institution must (and will ensure that Investigator A will) publicise the role of CCQ in funding the Project at every reasonable opportunity including (but not limited to) media interviews, promotional material, publications and presentations.
8.7. A party wishing to provide a public release of information in any media release pertaining to the use and outcomes derived from the Project must seek the consent of the other party of the content of the media release (such consent not to be unreasonably withheld) and must provide reasonable prior notification to the other party in advance of the public release.
Publications and Publicity. Publikace a propagace. Publication of the results of the Trial (including Trial Data) shall be permitted as set forth in the Protocol. Neither Party shall use the name of the other Party or any of its employees or representatives for promotional or advertising purposes without written permission from the other Party. However, Sponsor reserves the right to identify the Health Service Provider and/or the PI in association with a listing of the Protocol in the National Institutes of Health (NIH) Clinical Trials Data Bank, other publicly available listings of ongoing clinical trials, or other patient recruitment services or mechanisms. Zveřejnění výsledků klinického hodnocení (včetně dat klinického hodnocení) bude povoleno, jak je stanoveno v protokolu. Žádná smluvní strana nesmí používat jméno druhé smluvní strany nebo kteréhokoli z jejích zaměstnanců či zástupců k propagačním či reklamním účelům bez písemného souhlasu druhé smluvní strany. Zadavatel si nicméně vyhrazuje právo uvádět jméno poskytovatele zdravotních služeb a/nebo hlavního zkoušejícího v souvislosti s registrací protokolu v databázi národních ústavů pro klinická hodnocení ve zdravotnictví, v dalších veřejně dostupných registrech probíhajících klinických hodnocení nebo jiných službách či mechanismech zaměřených na nábor pacientů.
Publications and Publicity. 16.1 The Xxxxx Xxxxxx acknowledges that the MACULAR SOCIETY, as a medical research charity, is under an obligation to ensure that the results of research, which it funds in part or in whole, are used for the public good. In some circumstances, this obligation may be best achieved through the publication/presentation of Results in accordance with this Section 16 and in other circumstances via the protection of the Intellectual Property Rights in the Results and commercial exploitation of the same in accordance with Section 17.
16.2 Subject to Section 17.1, The Xxxxx Xxxxxx shall ensure timely publication/public presentation of the Results, including via (as appropriate) publication in an appropriate scientific journal and/or presentation at an appropriate scientific conference.
16.3 Copies of any articles or scientific papers published and details of presentations at scientific conferences reporting Results should be sent to the MACULAR SOCIETY at the time they are accepted for publication/presentation. The support of the MACULAR SOCIETY must be suitably recognised in each such publication/presentation. The MACULAR SOCIETY shall have an irrevocable, non-exclusive, sub-licensable, royalty free right to use (for the MACULAR SOCIETY’s non-commercial, charitable activities (including but not limited to use for fundraising in furtherance of the MACULAR SOCIETY’s charitable aims) any rights the Xxxxx Xxxxxx, Collaborator, Principal Investigator and/or Co-investigators may have/retain in any publication and/or presentation reporting the Results.
16.4 The Xxxxx Xxxxxx agrees that any publications and details of presentations provided under this Section 16 may be listed on the MACULAR SOCIETY’s website and/or shared by the MACULAR SOCIETY with specific donors or donor organisations to fulfil the MACULAR SOCIETY’s reporting and other requirements in relation to the Grant.
16.5 The Xxxxx Xxxxxx agrees that the MACULAR SOCIETY may, from time to time, cite the Grant and the Project as an example of the research it funds when applying to potential donors for financial support or when reporting to the relevant charity regulator(s) and/or the Association of Medical Research Charities. Personal data included in such citations will be processed in line with the Data Protection Xxx 0000 (as amended).
16.6 The Xxxxx Xxxxxx acknowledges that the provision of funding to support research (including the Grant) is dependent upon the MACULAR SOCIETY’s fund-raising activities. The Xx...
Publications and Publicity. Any publications which result from the Project, including without limitation, follow-up studies, research papers, articles, patent applications, or student theses or dissertations, shall be properly acknowledged and reported to TRDA in a timely manner. DynEco shall obtain the prior written approval of TRDA concerning the content and timing of news releases, articles, brochures, advertisements, speeches and other information releases concerning the performance of the Agreement. Notwithstanding the above, all information that is disseminated as a result of this Agreement shall contain the following statement which acknowledges support from the Department and TRDA: "Funding for this project was provided in part by the Department of Community Affairs/Florida Energy Office and the Technological Research and Developmental Authority."
